Why are pharma stocks down today? Here’s why Trump’s executive orders spark sell-off

Trump signed an executive order to boost US manufacturing by reducing approval time for pharmaceutical plants. This has caused a decline in pharma sector stocks, including Cipla and Dr Reddy’s. The order also aims to improve enforcement of active-ingredient source reporting by foreign producers and potentially publicly list non-compliant facilities.